Related Experiment Videos
Preparation of the major plasma fractions by solid-phase polyelectrolytes
The Journal of Laboratory and Clinical Medicine
|August 1, 1978
Summary
This study presents a flexible, non-denaturing batch method using solid-phase ethylene/maleic anhydride polymers for isolating albumin, gamma globulin, and crucial coagulation factors with high yield and purity.
Area of Science:
- Biochemistry
- Polymer Chemistry
- Biotechnology
Background:
- Fractionation of plasma proteins is essential for therapeutic applications.
- Existing methods often involve harsh conditions or organic solvents, potentially denaturing proteins.
- There is a need for efficient, non-denaturing methods for isolating specific protein fractions.
Purpose of the Study:
- To develop a flexible, integrated batch system for isolating and purifying albumin, gamma globulin, and coagulation factors.
- To utilize solid-phase ethylene/maleic anhydride polymers for protein adsorption and elution.
- To establish non-denaturing methods for high-purity protein fraction recovery.
Main Methods:
- Utilized solid-phase ethylene/maleic anhydride (PE) polymers (E-5 and E-100).
- Employed a three-step batch process: adsorption, elution, and concentration (ultrafiltration/PEG).
- Relied on electrostatic bonding, avoiding organic solvents for a non-denaturing approach.
Main Results:
- Achieved high yields and purity for various fractions: coagulation factors (63% yield, 200-fold purification), albumin (92% yield, 98.5% purity), and gamma globulin (92% yield, 97.5% purity).
- Demonstrated successful isolation of antihemophilic factor (AHF) and von Willebrand factor (vWF).
- Observed removal of Hepatitis B surface antigen (HBsAg) and infectivity during gamma globulin preparation with E-100.
Conclusions:
- The developed batch method is flexible, efficient, and non-denaturing for plasma protein fractionation.
- Solid-phase PE polymers offer a versatile platform for isolating clinically important proteins.
- The method shows potential for simultaneously purifying therapeutic proteins and removing viral contaminants.